相关实验视频

Updated: Jun 3, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.3K

免疫检查点抑制剂在质母细胞瘤IDHwt治疗:一个系统性审查

Archit Bharathwaj Baskaran1, Olivia A Kozel2, Omkar Venkatesh3

  • 1Department of Neurology, The University of Chicago, Chicago, IL 60637, USA.

Cancers
|January 8, 2025
PubMed
概括

免疫检查点抑制剂 (ICI) 在质母细胞瘤 (GBM) 治疗中显示出有限的疗效. 虽然已经进行了许多临床试验,但大多数患者没有受益,这凸显了基于生物标志物的选择的必要性.

关键词:
CTLA4 CTLA4 在线播放在LAG3中.在PD-L1中.在PD-L2中使用.这就是PD1 PD1.质母细胞瘤是一种质母细胞瘤.免疫检查点抑制抑制免疫检查点抑制

更多相关视频

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

15.8K
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.3K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472